A clinical study for evaluating the efficacy of the highly-concentrated oxygen nanobubble water -immune function, fatigue, autonomic nervous function and skin function
- Conditions
- one
- Registration Number
- JPRN-UMIN000018755
- Lead Sponsor
- Soiken Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Not provided
1) Subject receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subject having the chronic fatigue syndrome(CFS) , or subject deemed to have severe fatigue like idiopathic chronic fatigue by the investigator 3) Subject having a medical history of chest pain or syncope 4) Subject having an abnormality in the electrocardiogram 5)Subject having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations 6)Subjects who take regularly medical supplies or quasi-drugs which having the efficacy on recovery of fatigue or nutrition disorder at physical fatigue 7) Subjects who take regularly the highly-concentrated oxygen water 8) Subject having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 10)Female subjects who is pregnant or lactating, or intending to become pregnant during the study 11)Subject deemed unsuitable by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method